aspirin has been researched along with Weight Loss in 28 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Weight Loss: Decrease in existing BODY WEIGHT.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Aggressive medical management was defined as aspirin plus clopidogrel therapy for a minimum of 3 months, blood pressure control, statin use with a low-density lipoprotein (LDL) goal of <70 mg/dL, smoking cessation, and body mass index <25 kg/m(2)." | 3.79 | Early aggressive medical management for patients with symptomatic intracranial stenosis. ( Ayala, L; Cawley, CM; Dion, JE; Frankel, MR; Hammonds, LP; Kingston, C; Mitchell, B; Nahab, F; Tong, FC, 2013) |
| " Aspirin did not alter this effect of 60 h of fasting on insulin sensitivity (P = 0." | 3.74 | Prolonged fasting induces peripheral insulin resistance, which is not ameliorated by high-dose salicylate. ( Ackermans, MT; Allick, G; Endert, E; Romijn, JA; Sauerwein, HP; van der Crabben, SN, 2008) |
| "With aspirin, there was no change in deoxycholate but a decrease in arachidonate and no change in glycoprotein." | 2.67 | Roles of deoxycholate and arachidonate in pathogenesis of cholesterol gallstones in obese patients during rapid loss of weight. ( Bonorris, GG; Marks, JW; Schoenfield, LJ, 1991) |
| "Conservative treatment of coronary heart disease is the therapeutic mainstay and includes various measures aimed at achieving a general reduction of risks." | 2.43 | [Conservative treatment of coronary heart disease--current options]. ( Desch, S; Niebauer, J; Schuler, G, 2005) |
| "Takayasu arteritis is a granulomatous panarteritis that predominantly affects the aorta and its major branches." | 1.46 | Bilateral ocular ischemia-induced blindness as a presenting manifestation of Takayasu arteritis: a case report. ( Epafra, E; Janabi, M; Kazahura, P; Lyimo, F; Nicholaus, P; Pallangyo, P, 2017) |
| "Obesity is associated with inflammation." | 1.35 | The effect of anti-inflammatory (aspirin and/or statin) therapy on body weight in Type 2 diabetic individuals: EAT, a retrospective study. ( Boaz, M; Lisy, L; Wainstein, J; Zandman-Goddard, G, 2009) |
| "Aspirin was being taken by 56% of patients." | 1.30 | Secondary prevention of coronary heart disease in primary care: a healthy heart initiative. ( Armitage, M; Cox, P; Davies, J; Flanagan, DE; Paine, D, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.57) | 18.7374 |
| 1990's | 7 (25.00) | 18.2507 |
| 2000's | 8 (28.57) | 29.6817 |
| 2010's | 9 (32.14) | 24.3611 |
| 2020's | 3 (10.71) | 2.80 |
| Authors | Studies |
|---|---|
| Low, EE | 1 |
| Demb, J | 1 |
| Liu, L | 1 |
| Earles, A | 1 |
| Bustamante, R | 1 |
| Williams, CD | 1 |
| Provenzale, D | 1 |
| Kaltenbach, T | 1 |
| Gawron, AJ | 1 |
| Martinez, ME | 1 |
| Gupta, S | 1 |
| Gibson, KS | 1 |
| Hameed, AB | 1 |
| Oncel, S | 1 |
| Gupta, R | 1 |
| Wang, Q | 1 |
| Basson, MD | 1 |
| Mojkowska, A | 1 |
| Gazdzinski, S | 1 |
| Fraczek, M | 1 |
| Wyleżoł, M | 1 |
| Pallangyo, P | 1 |
| Epafra, E | 1 |
| Nicholaus, P | 1 |
| Lyimo, F | 1 |
| Kazahura, P | 1 |
| Janabi, M | 1 |
| Jomni, T | 1 |
| Bellakhal, S | 1 |
| Abouda, M | 1 |
| Abdelaali, I | 1 |
| Douggui, H | 1 |
| Rubino, F | 1 |
| Boaz, M | 1 |
| Lisy, L | 1 |
| Zandman-Goddard, G | 1 |
| Wainstein, J | 1 |
| Nahab, F | 1 |
| Kingston, C | 1 |
| Frankel, MR | 1 |
| Dion, JE | 1 |
| Cawley, CM | 1 |
| Mitchell, B | 1 |
| Hammonds, LP | 1 |
| Ayala, L | 1 |
| Tong, FC | 1 |
| Bikdeli, B | 1 |
| Barreto-Filho, JA | 1 |
| Drozda, JP | 1 |
| Holmes, DP | 1 |
| Wright, JS | 1 |
| Wall, HK | 1 |
| Briss, PA | 1 |
| Schooley, M | 1 |
| Darshan, J | 1 |
| Shaw, E | 1 |
| Green, B | 1 |
| Gallagher, PJ | 1 |
| Gadola, SD | 1 |
| Moser, M | 1 |
| Falkner, B | 1 |
| Weber, MA | 1 |
| Keilson, LM | 1 |
| Sander, O | 1 |
| Schneider, M | 1 |
| Bowman, TS | 1 |
| Kurth, T | 1 |
| Sesso, HD | 1 |
| Manson, JE | 1 |
| Gaziano, JM | 1 |
| van der Crabben, SN | 1 |
| Allick, G | 1 |
| Ackermans, MT | 1 |
| Endert, E | 1 |
| Romijn, JA | 1 |
| Sauerwein, HP | 1 |
| Desch, S | 1 |
| Schuler, G | 1 |
| Niebauer, J | 1 |
| Hochain, P | 1 |
| Berkelmans, I | 1 |
| Czernichow, P | 1 |
| Duhamel, C | 1 |
| Tranvouez, JL | 1 |
| Lerebours, E | 1 |
| Colin, R | 1 |
| Geissler, CA | 1 |
| Daly, PA | 2 |
| Krieger, DR | 2 |
| Dulloo, AG | 2 |
| Young, JB | 2 |
| Landsberg, L | 2 |
| Chowdhury, TA | 1 |
| Lasker, SS | 1 |
| Dyer, PH | 1 |
| Flanagan, DE | 1 |
| Cox, P | 1 |
| Paine, D | 1 |
| Davies, J | 1 |
| Armitage, M | 1 |
| Dyck, DJ | 1 |
| Marks, JW | 2 |
| Bonorris, GG | 2 |
| Schoenfield, LJ | 2 |
| Ransil, BJ | 1 |
| Broomfield, PH | 1 |
| Chopra, R | 1 |
| Sheinbaum, RC | 1 |
| Silverman, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Diet obEsity sMoking Epigenetics geneTics biomaRkers Physical Activity: An International Multicenter Case-control Study on Endogenous and Exogenous Risk Factors in Early-onset Colorectal Cancer[NCT05732623] | 2,300 participants (Anticipated) | Observational [Patient Registry] | 2022-12-05 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for aspirin and Weight Loss
| Article | Year |
|---|---|
[Temporal arteritis].
Topics: Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Catheter Ablation; Diagnosis, D | 2007 |
[Conservative treatment of coronary heart disease--current options].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Body Mass Index; Cho | 2005 |
Dietary fat intake, supplements, and weight loss.
Topics: Animals; Anti-Obesity Agents; Aspirin; Carnitine; Citrates; Dietary Fats; Dietary Supplements; Ephed | 2000 |
5 trials available for aspirin and Weight Loss
| Article | Year |
|---|---|
Eight-year change in body mass index and subsequent risk of cardiovascular disease among healthy non-smoking men.
Topics: Adult; Aspirin; beta Carotene; Body Mass Index; Cardiovascular Diseases; Cause of Death; Cohort Stud | 2007 |
Ephedrine, caffeine and aspirin: safety and efficacy for treatment of human obesity.
Topics: Adult; Aspirin; Caffeine; Drug Therapy, Combination; Energy Intake; Ephedrine; Female; Humans; Male; | 1993 |
Roles of deoxycholate and arachidonate in pathogenesis of cholesterol gallstones in obese patients during rapid loss of weight.
Topics: Arachidonic Acid; Arachidonic Acids; Aspirin; Cholelithiasis; Cholesterol; Deoxycholic Acid; Dinopro | 1991 |
Ephedrine, caffeine and aspirin promote weight loss in obese subjects.
Topics: Adult; Aspirin; Caffeine; Drug Therapy, Combination; Ephedrine; Female; Humans; Male; Obesity; Weigh | 1990 |
Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight.
Topics: Adult; Aspirin; Bile; Cholelithiasis; Cholesterol; Crystallization; Deoxycholic Acid; Double-Blind M | 1988 |
20 other studies available for aspirin and Weight Loss
| Article | Year |
|---|---|
Risk Factors for Early-Onset Colorectal Cancer.
Topics: Adolescent; Adult; Age Factors; Age of Onset; Aspirin; Case-Control Studies; Colonoscopy; Colorectal | 2020 |
Society for Maternal-Fetal Medicine Special Statement: Checklist for postpartum discharge of women with hypertensive disorders.
Topics: Aspirin; Blood Pressure Monitoring, Ambulatory; Checklist; Exercise; Female; Humans; Hypertension, P | 2020 |
ZINC40099027 Promotes Gastric Mucosal Repair in Ongoing Aspirin-Associated Gastric Injury by Activating Focal Adhesion Kinase.
Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cell Line; Creatini | 2021 |
Gastric Ulcer Hemorrhage - a Potential Life-Threatening Complication of Intragastric Balloon Treatment of Obesity.
Topics: Adult; Aspirin; Bariatric Surgery; Gastric Balloon; Gastrointestinal Hemorrhage; Helicobacter Infect | 2017 |
Bilateral ocular ischemia-induced blindness as a presenting manifestation of Takayasu arteritis: a case report.
Topics: Anti-Inflammatory Agents; Aspirin; Blindness; Computed Tomography Angiography; Dexamethasone; Female | 2017 |
[An atypical presentation of celiac disease: central retinal vein occlusion].
Topics: Adult; Anemia, Iron-Deficiency; Aspirin; Biopsy; Celiac Disease; Diet, Gluten-Free; Female; Humans; | 2015 |
Medical research: Time to think differently about diabetes.
Topics: Adipose Tissue; Animals; Aspirin; Bariatric Surgery; Bile Acids and Salts; Biomedical Research; Bloo | 2016 |
The effect of anti-inflammatory (aspirin and/or statin) therapy on body weight in Type 2 diabetic individuals: EAT, a retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diabetes Mellitus, | 2009 |
Early aggressive medical management for patients with symptomatic intracranial stenosis.
Topics: Aged; Antihypertensive Agents; Aspirin; Biomarkers; Blood Pressure; Body Mass Index; Cerebral Angiog | 2013 |
Reducing the cardiovascular disease burden: justified means for getting to the end.
Topics: Antihypertensive Agents; Aspirin; Cardiovascular Diseases; Evidence-Based Medicine; Health Policy; H | 2012 |
Performance measures in million hearts: 2 partners' perspective.
Topics: Antihypertensive Agents; Aspirin; Cardiovascular Diseases; Endpoint Determination; Evidence-Based Me | 2012 |
Million hearts--where population health and clinical practice intersect.
Topics: Antihypertensive Agents; Aspirin; Cardiovascular Diseases; Clinical Competence; Endpoint Determinati | 2012 |
Intestinal ischaemia and mesenteric necrosis in a heavy smoker.
Topics: Abdominal Pain; Aspirin; Diarrhea; Humans; Jejunal Diseases; Male; Mesenteric Arteries; Middle Aged; | 2013 |
Marathons: blood, sweat, and cheers. Marathon running may be extreme, but there are some lessons about exercise in it for all of us.
Topics: Aspirin; Drinking; Fibrinolytic Agents; Humans; Hyponatremia; Running; Weight Loss | 2003 |
The metabolic syndrome--what is it and how should it be managed?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clofibric Acid; Humans; Hydroxymethylglutaryl-CoA | 2006 |
Prolonged fasting induces peripheral insulin resistance, which is not ameliorated by high-dose salicylate.
Topics: Adult; Aspirin; Enzyme Inhibitors; Fasting; Glucose; Glucose Clamp Technique; Glutathione; Humans; I | 2008 |
Which patients taking non-aspirin non-steroidal anti-inflammatory drugs bleed? A case-control study.
Topics: Adrenal Cortex Hormones; Aged; Aged, 80 and over; Alcoholism; Anti-Inflammatory Agents, Non-Steroida | 1995 |
Effects of weight loss, ephedrine and aspirin on energy expenditure in obese women.
Topics: Adult; Aspirin; Basal Metabolism; Energy Metabolism; Ephedrine; Exercise; Female; Humans; Obesity; R | 1993 |
Comparison of secondary prevention measures after myocardial infarction in subjects with and without diabetes mellitus.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Blood Glucose; | 1999 |
Secondary prevention of coronary heart disease in primary care: a healthy heart initiative.
Topics: Antihypertensive Agents; Aspirin; Coronary Disease; Female; Health Education; Humans; Life Style; Ma | 1999 |